Update: 19.08.2025
Last week: 32 week 2025 (04.08.2025 - 10.08.2025)
Last full month: July 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 912 | 3.1% | 14.2% | 0.1 | 18 338 566 | 2.7% | 10.7% | 0 | 2.2% |
| MoM | 35 432 | -4.8% | 14.0% | 0.2 | 82 298 386 | -4.1% | 10.7% | 0.2 | -6.4% |
| YTD | 284 455 | 22.5% | 13.1% | 1.6 | 633 363 624 | 27.1% | 9.8% | 0.4 | 7.8% |
| MAT | 473 674 | 24.8% | 13.2% | 2.6 | 974 052 687 | 22.1% | 9.6% | 0.7 | 0.7% |
| BRAINMAX | |||||||||
| WoW | 1 982 | 5.5% | 100.0% | 0 | 6 931 704 | 5.5% | 100.0% | 0 | 5.5% |
| MoM | 8 367 | -9.6% | 100.0% | 0 | 28 979 330 | -8.5% | 100.0% | 0 | -9.6% |
| YTD | 74 737 | 98.7% | 100.0% | 0 | 258 438 529 | 94.6% | 100.0% | 0 | 98.7% |
| MAT | 119 784 | 99.6% | 100.0% | 0 | 412 333 584 | 94.6% | 100.0% | 0 | 99.6% |
| GOLDLINE PLUS | |||||||||
| WoW | 12 709 | -6.3% | 45.2% | -2.2 | 41 780 670 | -8.7% | 36.9% | -2.6 | -1.7% |
| MoM | 59 170 | -11.1% | 46.8% | 1.5 | 194 213 502 | -9.7% | 38.4% | 1.6 | -13.9% |
| YTD | 502 635 | -6.8% | 45.8% | 0.9 | 1 624 914 818 | -4.4% | 37.4% | 0.7 | -8.6% |
| MAT | 792 229 | -6.0% | 46.0% | 0.6 | 2 528 315 112 | -5.2% | 37.6% | -0.3 | -7.1% |
| MIGRENIUM | |||||||||
| WoW | 7 986 | 4.9% | 0.3% | 0 | 2 831 986 | 4.3% | 0.5% | 0 | 0.0% |
| MoM | 33 596 | -4.9% | 0.3% | 0 | 11 944 032 | -4.5% | 0.4% | -0.1 | 6.0% |
| YTD | 258 647 | -31.1% | 0.3% | -0.2 | 91 074 226 | -21.7% | 0.5% | -0.2 | 5.4% |
| MAT | 450 886 | -26.4% | 0.4% | -0.1 | 156 453 019 | -5.5% | 0.5% | -0.1 | 2.1% |
| MODELAX-N | |||||||||
| WoW | 24 322 | -3.0% | 19.0% | -0.3 | 13 656 023 | -2.9% | 14.9% | 0.8 | 1.7% |
| MoM | 109 558 | -17.1% | 18.9% | -4.5 | 61 104 818 | -14.6% | 13.7% | -3.1 | 2.8% |
| YTD | 902 235 | -3.5% | 20.1% | -2.8 | 482 632 244 | 19.9% | 14.5% | -0.2 | 9.8% |
| MAT | 1 430 711 | 1.9% | 20.0% | -1.1 | 739 311 392 | 30.8% | 14.1% | 1 | 7.7% |
| REDUXIN | |||||||||
| WoW | 9 401 | 3.2% | 33.4% | 1.6 | 51 040 628 | 3.4% | 45.0% | 2.5 | -1.7% |
| MoM | 39 941 | -15.6% | 31.6% | -0.6 | 216 342 541 | -16.7% | 42.8% | -1.6 | -13.9% |
| YTD | 347 644 | -12.0% | 31.7% | -1.2 | 1 895 295 400 | -10.4% | 43.7% | -2 | -8.6% |
| MAT | 548 022 | -8.7% | 31.8% | -0.6 | 2 943 775 147 | -6.0% | 43.8% | -0.7 | -7.1% |
| REDUXIN FORTE | |||||||||
| WoW | 2 914 | -0.2% | 10.4% | 0.2 | 13 578 929 | -2.6% | 12.0% | 0 | -1.7% |
| MoM | 13 181 | -11.7% | 10.4% | 0.3 | 61 917 260 | -8.5% | 12.2% | 0.7 | -13.9% |
| YTD | 110 560 | 4.2% | 10.1% | 1.2 | 505 513 994 | 9.9% | 11.6% | 1.7 | -8.6% |
| MAT | 171 771 | 3.4% | 10.0% | 1 | 767 321 235 | 8.2% | 11.4% | 1.3 | -7.1% |
| SALVISAR | |||||||||
| WoW | 8 767 | 3.8% | 1.3% | 0.1 | 4 747 426 | 5.0% | 1.3% | 0.1 | -0.1% |
| MoM | 37 734 | -12.3% | 1.3% | -0.1 | 20 254 565 | -11.7% | 1.3% | -0.1 | -3.9% |
| YTD | 377 717 | 18.3% | 1.6% | 0.3 | 190 270 593 | 46.4% | 1.6% | 0.4 | -2.5% |
| MAT | 630 277 | 25.2% | 1.7% | 0.4 | 301 204 661 | 57.3% | 1.6% | 0.5 | -4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 284 455 | 22.5% | 13.1% | 1.6 | 633 363 624 | 27.1% | 9.8% | 0.4 | 7.8% |
| BRAINMAX | 74 737 | 98.7% | 100.0% | 0 | 258 438 529 | 94.6% | 100.0% | 0 | 98.7% |
| GOLDLINE PLUS | 502 635 | -6.8% | 45.8% | 0.9 | 1 624 914 818 | -4.4% | 37.4% | 0.7 | -8.6% |
| MIGRENIUM | 258 647 | -31.1% | 0.3% | -0.2 | 91 074 226 | -21.7% | 0.5% | -0.2 | 5.4% |
| MODELAX-N | 902 235 | -3.5% | 20.1% | -2.8 | 482 632 244 | 19.9% | 14.5% | -0.2 | 9.8% |
| REDUXIN CAPS | 347 644 | -12.0% | 31.7% | -1.2 | 1 895 295 400 | -10.4% | 43.7% | -2 | -8.6% |
| REDUXIN FORTE | 110 560 | 4.2% | 10.1% | 1.2 | 505 513 994 | 9.9% | 11.6% | 1.7 | -8.6% |
| SALVISAR | 377 717 | 18.3% | 1.6% | 0.3 | 190 270 593 | 46.4% | 1.6% | 0.4 | -2.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 473 674 | 24.8% | 13.2% | 2.6 | 974 052 687 | 22.1% | 9.6% | 0.7 | 0.7% |
| BRAINMAX | 119 784 | 99.6% | 100.0% | 0 | 412 333 584 | 94.6% | 100.0% | 0 | 99.6% |
| GOLDLINE PLUS | 792 229 | -6.0% | 46.0% | 0.6 | 2 528 315 112 | -5.2% | 37.6% | -0.3 | -7.1% |
| MIGRENIUM | 450 886 | -26.4% | 0.4% | -0.1 | 156 453 019 | -5.5% | 0.5% | -0.1 | 2.1% |
| MODELAX-N | 1 430 711 | 1.9% | 20.0% | -1.1 | 739 311 392 | 30.8% | 14.1% | 1 | 7.7% |
| REDUXIN CAPS | 548 022 | -8.7% | 31.8% | -0.6 | 2 943 775 147 | -6.0% | 43.8% | -0.7 | -7.1% |
| REDUXIN FORTE | 171 771 | 3.4% | 10.0% | 1 | 767 321 235 | 8.2% | 11.4% | 1.3 | -7.1% |
| SALVISAR | 630 277 | 25.2% | 1.7% | 0.4 | 301 204 661 | 57.3% | 1.6% | 0.5 | -4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 912 | 3.1% | 14.2% | 0.1 | 18 338 566 | 2.7% | 10.7% | 0 | 2.2% |
| BRAINMAX | 1 982 | 5.5% | 100.0% | 0 | 6 931 704 | 5.5% | 100.0% | 0 | 5.5% |
| GOLDLINE PLUS | 12 709 | -6.3% | 45.2% | -2.2 | 41 780 670 | -8.7% | 36.9% | -2.6 | -1.7% |
| MIGRENIUM | 7 986 | 4.9% | 0.3% | 0 | 2 831 986 | 4.3% | 0.5% | 0 | 0.0% |
| MODELAX-N | 24 322 | -3.0% | 19.0% | -0.3 | 13 656 023 | -2.9% | 14.9% | 0.8 | 1.7% |
| REDUXIN CAPS | 9 401 | 3.2% | 33.4% | 1.6 | 51 040 628 | 3.4% | 45.0% | 2.5 | -1.7% |
| REDUXIN FORTE | 2 914 | -0.2% | 10.4% | 0.2 | 13 578 929 | -2.6% | 12.0% | 0 | -1.7% |
| SALVISAR | 8 767 | 3.8% | 1.3% | 0.1 | 4 747 426 | 5.0% | 1.3% | 0.1 | -0.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 35 432 | -4.8% | 14.0% | 0.2 | 82 298 386 | -4.1% | 10.7% | 0.2 | -6.4% |
| BRAINMAX | 8 367 | -9.6% | 100.0% | 0 | 28 979 330 | -8.5% | 100.0% | 0 | -9.6% |
| GOLDLINE PLUS | 59 170 | -11.1% | 46.8% | 1.5 | 194 213 502 | -9.7% | 38.4% | 1.6 | -13.9% |
| MIGRENIUM | 33 596 | -4.9% | 0.3% | 0 | 11 944 032 | -4.5% | 0.4% | -0.1 | 6.0% |
| MODELAX-N | 109 558 | -17.1% | 18.9% | -4.5 | 61 104 818 | -14.6% | 13.7% | -3.1 | 2.8% |
| REDUXIN CAPS | 39 941 | -15.6% | 31.6% | -0.6 | 216 342 541 | -16.7% | 42.8% | -1.6 | -13.9% |
| REDUXIN FORTE | 13 181 | -11.7% | 10.4% | 0.3 | 61 917 260 | -8.5% | 12.2% | 0.7 | -13.9% |
| SALVISAR | 37 734 | -12.3% | 1.3% | -0.1 | 20 254 565 | -11.7% | 1.3% | -0.1 | -3.9% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs